Independent

[flipper44]

So, logic dictates that if NWBO was waiting for Survaxm’s internal 2b control arm 91 to 99 patient (but External Control Arm for DCVax-l) comparable to further substantiate NWBO’s upcoming NICE submission; NWBO were “not yet in a position” to make their evidence submission when I contacted NICE a few weeks back.

“Yet”

Get it?

Note: If MimiVax and NWBO have been playing pattycake these past few years, per my hypothesis, MimiVax should, in a kind and decent world, imo, already or very very soon (days) be sharing their control arm data results, because they also work with Roswell, and what good can come from Mimivax’s likely GBM failure other than providing solid relevant control arm data under the new definition inclusion/exclusion of GBM.